Related Experiment Video
Updated: Apr 12, 2026
09:45
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
Published on: April 21, 2018
14.1K
Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective
Johanna Stoevesandt1, Christine Hosp1, Andreas Kerstan1
1Department of Dermatology and Allergy, University Hospital Würzburg, Würzburg, Germany.
Summary
Cardiovascular medications, including beta-blockers and ACE inhibitors, do not negatively impact the safety or effectiveness of Hymenoptera venom immunotherapy (VIT). This study found no increased risks, suggesting concurrent use is safe for patients undergoing VIT.
Area of Science:
- Immunology
- Cardiology
- Allergy and Clinical Immunology
Background:
- Cardiovascular medications' role during Hymenoptera venom immunotherapy (VIT) remains controversial.
- Concerns exist regarding potential risks of beta-blockers (BBs) and angiotensin-converting enzyme inhibitors (ACEIs) during VIT.
Purpose of the Study:
- To evaluate the impact of BBs and/or ACEIs on the long-term safety and efficacy of VIT.
- To assess cardiovascular medication's influence on VIT outcomes in patients with cardiovascular comorbidities.
Main Methods:
- Retrospective analysis of standardized questionnaires from patients with cardiovascular comorbidities undergoing VIT maintenance.
- Data collected on VIT course, Hymenoptera re-stings, and concurrent medication use.
Main Results:
- No increased adverse event rates observed in patients taking cardiovascular medications during VIT.
- Reaction rates were surprisingly lower in patients on cardiovascular medication, particularly ACEIs.
- No evidence of increased relapse or hospitalization rates following Hymenoptera stings in patients on cardiovascular medication.
Conclusions:
- Concurrent use of cardiovascular medications does not compromise the safety or efficacy of Hymenoptera VIT.
- Findings suggest that BBs and ACEIs can be safely used in patients undergoing VIT.
Related Concept Videos
00:42Cross-reactivity
34.0K
Overview
34.0K
01:01Hypersensitivity Reactions: Cytolytic Reactions
143
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
143
02:06Allergic Reactions
34.2K
Overview
34.2K
01:30Allergic Reactions: Anaphylaxis
210
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
210
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K